Simulations Plus Inc. Common Stock (SLP)
StalwartFairStock Score: 60/100 — STEADY
Key Financials
| Current Price | $13.34 |
| Market Cap | $290M |
| P/E Ratio | -4.28 |
| ROE | -38.84% |
| Dividend Yield | —% |
| Sector | Healthcare |
Strengths
- Generates $17 million in annual free cash flow (5.9% yield on market cap)
- Strong Piotroski F-Score of 7/9 indicating robust financial health across profitability, leverage, and efficiency metrics
- Conservative balance sheet with debt-to-equity of just 0.00, providing financial flexibility
- Altman Z-Score of 14.1 confirms minimal bankruptcy risk and strong solvency
AI Analysis
Simulations Plus Inc. Common Stock is a micro-cap healthcare company valued at $290 million. The business generates $81 million in annual revenue with a 5.6% net margin and $17 million in free cash flow. From a quality standpoint, Simulations shows solid Piotroski F-Score of 7/9 and Altman Z-Score of 14.1 confirms fortress-level solvency. On valuation, the stock is 1.9% FCF yield. Growth dynamics show revenue growing at 8.3% and profit growth of 47.5%. Our composite FairStock Score of 60/100 reflects above-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $17 million in annual free cash flow (5.9% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the healthcare space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer